Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High cure rate with a moderately intensive treatment regimen in non-high-risk childhood acute lymphoblastic leukemia. Results of protocol ALL VI from the Dutch Childhood Leukemia Study Group.
Veerman AJ, Hählen K, Kamps WA, Van Leeuwen EF, De Vaan GA, Solbu G, Suciu S, Van Wering ER, Van der Does-Van der Berg A. Veerman AJ, et al. Among authors: solbu g. J Clin Oncol. 1996 Mar;14(3):911-8. doi: 10.1200/JCO.1996.14.3.911. J Clin Oncol. 1996. PMID: 8622039 Free article.
Dutch Childhood Leukemia Study Group: early results of study ALL VI (1984-1988).
Veerman AJ, Hählen K, Kamps WA, Vanleeuwen EF, de Vaan GA, Vanwering ER, Vanderdoes-Vandenberg A, Solbu G, Suciu S. Veerman AJ, et al. Among authors: solbu g. Haematol Blood Transfus. 1990;33:473-7. doi: 10.1007/978-3-642-74643-7_85. Haematol Blood Transfus. 1990. PMID: 2182439 Clinical Trial. No abstract available.
Effectiveness of rubidomycin in induction therapy with vincristine, prednisone, and L-asparaginase for standard risk childhood acute lymphocytic leukemia: results of a Dutch phase III study (ALL V). A report on behalf of the Dutch Childhood Leukemia Study Group (DCLSG).
van der Does-van den Berg A, van Wering ER, Suciu S, Solbu G, van 't Veer MB, Rammeloo JA, de Koning J, van Zanen GE. van der Does-van den Berg A, et al. Among authors: solbu g. Am J Pediatr Hematol Oncol. 1989 Summer;11(2):125-33. Am J Pediatr Hematol Oncol. 1989. PMID: 2665546 Clinical Trial.
On the value of intensive remission-induction chemotherapy in elderly patients of 65+ years with acute myeloid leukemia: a randomized phase III study of the European Organization for Research and Treatment of Cancer Leukemia Group.
Löwenberg B, Zittoun R, Kerkhofs H, Jehn U, Abels J, Debusscher L, Cauchie C, Peetermans M, Solbu G, Suciu S, et al. Löwenberg B, et al. Among authors: solbu g. J Clin Oncol. 1989 Sep;7(9):1268-74. doi: 10.1200/JCO.1989.7.9.1268. J Clin Oncol. 1989. PMID: 2475589 Clinical Trial.
Intermediate and high dose Ara-C and m-AMSA for remission induction and consolidation treatment of patients with acute myeloid leukemia: an EORTC Leukemia Cooperative Group phase II study.
Willemze R, Jager U, Jehn U, Stryckmans P, Bury J, Suciu S, Solbu G, Zittoun R, Burghouts J, Löwenberg B, et al. Willemze R, et al. Among authors: solbu g. Eur J Cancer Clin Oncol. 1988 Nov;24(11):1721-5. doi: 10.1016/0277-5379(88)90073-9. Eur J Cancer Clin Oncol. 1988. PMID: 3061827
Granulocyte-macrophage colony-stimulating factor associated with induction treatment of acute myelogenous leukemia: a randomized trial by the European Organization for Research and Treatment of Cancer Leukemia Cooperative Group.
Zittoun R, Suciu S, Mandelli F, de Witte T, Thaler J, Stryckmans P, Hayat M, Peetermans M, Cadiou M, Solbu G, Petti MC, Willemze R. Zittoun R, et al. Among authors: solbu g. J Clin Oncol. 1996 Jul;14(7):2150-9. doi: 10.1200/JCO.1996.14.7.2150. J Clin Oncol. 1996. PMID: 8683249 Free article. Clinical Trial.
Systemic effect of intrathecal methotrexate during the initial phase of treatment of childhood acute lymphoblastic leukemia. The European Organization for Research and Treatment of Cancer Children's Leukemia Cooperative Group.
Thyss A, Suciu S, Bertrand Y, Mazingue F, Robert A, Vilmer E, Mechinaud F, Benoit Y, Brock P, Ferster A, Lutz P, Boutard P, Marguerite G, Plouvier E, Michel G, Plantaz D, Munzer M, Rialland X, Chantraine JM, Norton L, Solbu G, Philippe N, Otten J. Thyss A, et al. Among authors: solbu g. J Clin Oncol. 1997 May;15(5):1824-30. doi: 10.1200/JCO.1997.15.5.1824. J Clin Oncol. 1997. PMID: 9164191
Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy--the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organization for the Research and Treatment of Cancer and the Dutch-Belgian Hemato-Oncology Cooperative Hovon Group.
Löwenberg B, Suciu S, Archimbaud E, Haak H, Stryckmans P, de Cataldo R, Dekker AW, Berneman ZN, Thyss A, van der Lelie J, Sonneveld P, Visani G, Fillet G, Hayat M, Hagemeijer A, Solbu G, Zittoun R. Löwenberg B, et al. Among authors: solbu g. J Clin Oncol. 1998 Mar;16(3):872-81. doi: 10.1200/JCO.1998.16.3.872. J Clin Oncol. 1998. PMID: 9508168 Free article. Clinical Trial.
43 results